Physician profile
Kofi Om Atiemo
NPI 1467688812
$451.11
in general payments reported to CMS, 2019-2025
9 companies · $89.82 in 2025
The $89.82 reported for 2025 was less than what a typical Transplant Surgery provider received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $77.90 · 2020: $39.46 · 2021: $14.90 · 2022: $25.45 · 2023: $204 · 2025: $89.82.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $154.48 | 2023 | Visera Elite II Video System Center Olympus Otv-S300, Olympus |
| Intuitive Surgical, INC. | $77.90 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $49.10 | 2023 | Xifaxan |
| Eisai INC. | $39.46 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $34.23 | 2025 | Entyvio |
| Qol Medical, LLC | $32.73 | 2025 | Sucraid |
| Ethicon US, LLC | $25.45 | 2022 | |
| Axogen | $22.86 | 2025 | |
| Veloxis Pharmaceuticals, INC. | $14.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kofi Atiemo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.